310 related articles for article (PubMed ID: 24884830)
1. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
2. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter.
Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W
Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.
Dong WW; Li J; Li J; Zhang P; Wang ZH; Sun W; Zhang H
Int J Exp Pathol; 2018 Feb; 99(1):15-21. PubMed ID: 29655286
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
[TBL] [Abstract][Full Text] [Related]
5. PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
Qiu YB; Liao LY; Jiang R; Xu M; Xu LW; Chen GG; Liu ZM
Sci Rep; 2019 Jan; 9(1):1032. PubMed ID: 30705367
[TBL] [Abstract][Full Text] [Related]
6. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
Ahn HY; Song RY; Ahn HS; Kim HS
Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
8. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
9. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
10. Expression of oestrogen-α receptor in papillary thyroid carcinoma and its association with metastasis.
Ab Halim SA; Lee SK; Mustangin M; Mohd Saleh MF; Shah SA; Md Isa N
Malays J Pathol; 2020 Dec; 42(3):415-422. PubMed ID: 33361723
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of human thyroid carcinoma and goiter cells in vitro by the isoflavone derivative 7-(O)-carboxymethyl daidzein conjugated to N-t-boc-hexylenediamine.
Somjen D; Grafi-Cohen M; Weisinger G; Izkhakov E; Sharon O; Kraiem Z; Fliss D; Zikk D; Kohen F; Stern N
Thyroid; 2012 Aug; 22(8):809-13. PubMed ID: 22799572
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor α induces prosurvival autophagy in papillary thyroid cancer via stimulating reactive oxygen species and extracellular signal regulated kinases.
Fan D; Liu SY; van Hasselt CA; Vlantis AC; Ng EK; Zhang H; Dong Y; Ng SK; Chu R; Chan AB; Du J; Wei W; Liu X; Liu Z; Xing M; Chen GG
J Clin Endocrinol Metab; 2015 Apr; 100(4):E561-71. PubMed ID: 25594859
[TBL] [Abstract][Full Text] [Related]
13. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
14. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of Estrogen Receptors Is Associated with Tumorigenesis in Papillary Thyroid Carcinoma.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162942
[TBL] [Abstract][Full Text] [Related]
16. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
[TBL] [Abstract][Full Text] [Related]
17. Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.
Dai YJ; Qiu YB; Jiang R; Xu M; Zhao L; Chen GG; Liu ZM
Sci Rep; 2017 Sep; 7(1):12279. PubMed ID: 28947799
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma.
Lee YM; Lee JB
J Int Med Res; 2013 Jun; 41(3):825-34. PubMed ID: 23569038
[TBL] [Abstract][Full Text] [Related]
20. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]